TNYA
Tenaya Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$0.82+0.15%
Price as of Jul 20, 2026
TNYA valuation
Tenaya Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 9.47x
- P/E 2028E
- 0.66x
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.67x
- Price / sales
- 789.10x
- Price / cash flow
- -2.76x
Enterprise value
- Enterprise value
- $106.8M
- EV / sales
- 474.57x
- EV / EBITDA
- -1.41x
- EV / EBIT
- -1.24x
- Market cap
- $177.5M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.